# OnCo record paper-fader-trastuzumab-uterine-serous-jco-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-fader-trastuzumab-uterine-serous-jco-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-fader-trastuzumab-uterine-serous-jco-2018" ;
  schema:name "Carboplatin-paclitaxel with or without trastuzumab in HER2-positive advanced or recurrent uterine serous carcinoma"@en ;
  schema:description "Adding trastuzumab to chemotherapy for HER2-positive uterine serous carcinoma, an aggressive endometrial cancer, lengthened progression-free survival by about four months and later showed a survival benefit, making HER2 testing routine in this subtype."@en ;
  schema:url <https://onco.cc/key-papers/paper-fader-trastuzumab-uterine-serous-jco-2018/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.2017.76.5966>, <https://pubmed.ncbi.nlm.nih.gov/29584549/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.2017.76.5966> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Fader AN, Roque DM, Siegel E, et al." ;
  onco:cancers <https://onco.cc/cancers/endometrial-p53-abnormal/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/trastuzumab/> ;
  onco:journals <https://onco.cc/journals/jco/> .